Ransomware victim disclosure
← All victimsJohnson & Johnson Innovative Medicine
Claimed by Spacebears · listed 2 months ago
Status timeline
- ListedMay 4, 2026
- Data leakeddate unknown
At a glance
- Group
- Spacebears
- Status
- Data leaked
- Country
- United States
- Sector
- Healthcare
- Listed on leak site
- May 4, 2026
- Data size
- 1.6 TB
About the victim
AI dossier — public-source company profileJohnson & Johnson Innovative Medicine, formerly known as Janssen Pharmaceuticals, is the pharmaceutical division of Johnson & Johnson, headquartered in New Brunswick, New Jersey. The division specializes in the research, development, and commercialization of prescription medicines across therapeutic areas including oncology, immunology, neuroscience, and infectious disease. It operates globally and is one of the largest pharmaceutical enterprises in the world.
- Industry
- Pharmaceutical Research & Development
- Address
- One Johnson & Johnson Plaza, New Brunswick, NJ 08933, USA
- Employees
- 10000+
- Founded
- 1886
Attack summary
Severity: critical — The victim is a major pharmaceutical division of a Fortune 500 healthcare corporation. The disclosed status is 'data_published', indicating confirmed exfiltration of data that is highly likely to include regulated information such as clinical trial data, patient-related records, proprietary drug research, and sensitive business data at significant scale.The spacebears ransomware group claims to have attacked Johnson & Johnson Innovative Medicine and has published data, indicating confirmed exfiltration; however, no specific data size or ransom demand was stated in the post.
Data the group says was taken
AI dossier — extracted from the leak post- Pharmaceutical research data
- Corporate business data
- Potentially proprietary drug development records
What the group claims
Johnson & Johnson Innovative Medicine (formerly known as Janssen Pharmaceuticals) is the pharmaceutical division of the American corporation Johnson & Johnson, specializing in the development and production of revolutionary medicines. The company focuses on creating treatments for the most complex diseases, transforming the future of healthcare.-CAR-T Research https://www.jnj.com/innovativemedicine/
The leak post
captured from the group's site## Johnson & Johnson Innovative Medicine Johnson & Johnson Innovative Medicine (formerly known as Janssen Pharmaceuticals) is the pharmaceutical division of the American corporation Johnson & Johnson, specializing in the development and production of revolutionary medicines. The company focuses on creating treatments for the most complex diseases, transforming the future of healthcare.
Screenshot of the leak post

Sources
Source
Indexed 2 months agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
Is this your supplier? Your competitor? You?
Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

